These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 9543159

  • 21. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB, Niewiadomski P, Nowak JZ.
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [Abstract] [Full Text] [Related]

  • 22. Receptors for pituitary adenylate cyclase activating peptides in human pituitary adenomas.
    Robberecht P, Vertongen P, Velkeniers B, de Neef P, Vergani P, Raftopoulos C, Brotchi J, Hooghe-Peters EL, Christophe J.
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1235-9. PubMed ID: 8077316
    [Abstract] [Full Text] [Related]

  • 23. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D, Anouar Y, Jegou S, Fournier A, Vaudry H.
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [Abstract] [Full Text] [Related]

  • 24. Ontogeny of pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in the rat cerebellum: a quantitative autoradiographic study.
    Basille M, Gonzalez BJ, Fournier A, Vaudry H.
    Brain Res Dev Brain Res; 1994 Oct 14; 82(1-2):81-9. PubMed ID: 7842522
    [Abstract] [Full Text] [Related]

  • 25. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin.
    Reubi JC, Läderach U, Waser B, Gebbers JO, Robberecht P, Laissue JA.
    Cancer Res; 2000 Jun 01; 60(11):3105-12. PubMed ID: 10850463
    [Abstract] [Full Text] [Related]

  • 26. Effects of pituitary adenylate cyclase-activating polypeptide in the pituitary: activation of two signal transduction pathways in the gonadotrope-derived alpha T3-1 cell line.
    Schomerus E, Poch A, Bunting R, Mason WT, McArdle CA.
    Endocrinology; 1994 Jan 01; 134(1):315-23. PubMed ID: 7903932
    [Abstract] [Full Text] [Related]

  • 27. Expression and function of vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and their receptors in the human adrenal gland.
    Mazzocchi G, Malendowicz LK, Rebuffat P, Gottardo L, Nussdorfer GG.
    J Clin Endocrinol Metab; 2002 Jun 01; 87(6):2575-80. PubMed ID: 12050216
    [Abstract] [Full Text] [Related]

  • 28. Characterization and localization of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites in the brain of the frog Rana ridibunda.
    Jeandel L, Yon L, Chartrel N, Gonzalez B, Fournier A, Conlon JM, Vaudry H.
    J Comp Neurol; 1999 Sep 20; 412(2):218-28. PubMed ID: 10441752
    [Abstract] [Full Text] [Related]

  • 29. Characterization of ocular receptors for pituitary adenylate cyclase activating polypeptide (PACAP) and their coupling to adenylate cyclase.
    Nilsson SF, De Neef P, Robberecht P, Christophe J.
    Exp Eye Res; 1994 Apr 20; 58(4):459-67. PubMed ID: 7925682
    [Abstract] [Full Text] [Related]

  • 30. PAC1 receptor activation by PACAP-38 mediates Ca2+ release from a cAMP-dependent pool in human fetal adrenal gland chromaffin cells.
    Payet MD, Bilodeau L, Breault L, Fournier A, Yon L, Vaudry H, Gallo-Payet N.
    J Biol Chem; 2003 Jan 17; 278(3):1663-70. PubMed ID: 12429744
    [Abstract] [Full Text] [Related]

  • 31. Distribution and functional characterization of pituitary adenylate cyclase-activating polypeptide receptors in the brain of non-human primates.
    Jolivel V, Basille M, Aubert N, de Jouffrey S, Ancian P, Le Bigot JF, Noack P, Massonneau M, Fournier A, Vaudry H, Gonzalez BJ, Vaudry D.
    Neuroscience; 2009 May 05; 160(2):434-51. PubMed ID: 19236905
    [Abstract] [Full Text] [Related]

  • 32. Pituitary adenylate cyclase-activating polypeptide and its receptors in amphibians.
    Yon L, Alexandre D, Montéro M, Chartrel N, Jeandel L, Vallarino M, Conlon JM, Kikuyama S, Fournier A, Gracia-Navarro F, Roubos E, Chow B, Arimura A, Anouar Y, Vaudry H.
    Microsc Res Tech; 2001 Aug 01; 54(3):137-57. PubMed ID: 11458398
    [Abstract] [Full Text] [Related]

  • 33. Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.
    Cavallaro S, Copani A, D'Agata V, Musco S, Petralia S, Ventra C, Stivala F, Travali S, Canonico PL.
    Mol Pharmacol; 1996 Jul 01; 50(1):60-6. PubMed ID: 8700120
    [Abstract] [Full Text] [Related]

  • 34. PAC1 receptors in chick cerebral cortex: characterization by binding of pituitary adenylate cyclase-activating polypeptide, [125I]-PACAP27.
    Zawilska JB, Niewiadomski P, Nowak JZ.
    Neurosci Lett; 2003 Feb 27; 338(2):155-8. PubMed ID: 12566176
    [Abstract] [Full Text] [Related]

  • 35. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
    Rawlings SR, Piuz I, Schlegel W, Bockaert J, Journot L.
    Endocrinology; 1995 May 27; 136(5):2088-98. PubMed ID: 7720658
    [Abstract] [Full Text] [Related]

  • 36. Localization and characterization of pituitary adenylate cyclase-activating polypeptide receptors in the human cerebellum during development.
    Basille M, Cartier D, Vaudry D, Lihrmann I, Fournier A, Freger P, Gallo-Payet N, Vaudry H, Gonzalez B.
    J Comp Neurol; 2006 Jun 01; 496(4):468-78. PubMed ID: 16572459
    [Abstract] [Full Text] [Related]

  • 37. Expression of pituitary adenylate cyclase activating polypeptide and its type I receptor mRNAs in human placenta.
    Koh PO, Won CK, Noh HS, Cho GJ, Choi WS.
    J Vet Sci; 2005 Mar 01; 6(1):1-5. PubMed ID: 15785117
    [Abstract] [Full Text] [Related]

  • 38. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
    Cai Y, Xin X, Shim GJ, Mokuno Y, Uehara H, Yamada T, Agui T, Matsumoto K.
    Endocrinology; 1997 Jun 01; 138(6):2515-20. PubMed ID: 9165043
    [Abstract] [Full Text] [Related]

  • 39. Pituitary adenylate cyclase-activating polypeptide directly stimulates LH and FSH secretion by human pituitary gonadotrophinomas.
    Petersen B, Buchfelder M, Fahlbusch R, Adams EF.
    Exp Clin Endocrinol Diabetes; 1996 Jun 01; 104(3):250-5. PubMed ID: 8817243
    [Abstract] [Full Text] [Related]

  • 40. Novel splice variants of type I pituitary adenylate cyclase-activating polypeptide receptor in frog exhibit altered adenylate cyclase stimulation and differential relative abundance.
    Alexandre D, Vaudry H, Grumolato L, Turquier V, Fournier A, Jégou S, Anouar Y.
    Endocrinology; 2002 Jul 01; 143(7):2680-92. PubMed ID: 12072402
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.